The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

Direct stenting of de novo coronary stenoses with tacrolimus-eluting versus carbon-coated carbostents. The randomized JUPITER II trial

EuroIntervention 2006;2:45-52 - DOI10.4244/EIJV2I1A09.

1. Institut Jacques Cartier, Massy, France; 2. Herz-Zentrum Bad Krozingen, Bad Krozingen, Germany; 3. Hôpital de Rangueil, Toulouse, France; 4. Hospital Clinico San Carlos, Madrid, Spain; 5. University Medical Center Radboud, Nijmegen, The Netherlands; 6.

Aims: Drug-eluting stents are being increasingly used for the treatment of de novo coronary lesions. This trial compared the performance of tacrolimus-eluting stents (TES) with that of equi

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Revascularization strategies of coronary multiple vessel disease in the Drug Eluting Stent Era: one year follow-up results of the ERACI III Trial